FDA Approves New Drug to Treat Diabetes

Today's blog features the news that the FDA recently approved a new drug to treat diabetes. Admelog is the first short-acting "follow-on" insulin product to improve control in blood sugar levels in adults and pediatric patients.

“With today’s approval, we are providing an important short-acting insulin option for patients that meets our standards for safety and effectiveness,” said Mary T. Thanh Hai, M.D., deputy director of the Office of New Drug Evaluation II in the FDA’s Center for Drug Evaluation and Research.

To learn more about this new drug please read the full article HERE!

Performance Pharmacy Solutions (PPS) is a unique pharmacy benefit procurement platform developed by HORIZON Health Ventures to efficiently and effectively place, manage and oversee our self-funded client's pharmacy benefit management programs. The PPS platform provides turnkey solutions with proven market-leading PBM partners that offer, on average, 10-15% savings.